141 related articles for article (PubMed ID: 28279572)
21. Diabetic retinal pigment epitheliopathy: fundus autofluorescence and spectral-domain optical coherence tomography findings.
Kang EC; Seo Y; Byeon SH
Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1931-1940. PubMed ID: 27052841
[TBL] [Abstract][Full Text] [Related]
22. Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes.
Parravano M; Ziccardi L; Borrelli E; Costanzo E; Frontoni S; Picconi F; Parisi V; Sacconi R; Di Renzo A; Varano M; Querques G
Sci Rep; 2021 Jul; 11(1):15183. PubMed ID: 34312425
[TBL] [Abstract][Full Text] [Related]
23. Photoreceptor degeneration in ABCA4-associated retinopathy and its genetic correlates.
Pfau M; Cukras CA; Huryn LA; Zein WM; Ullah E; Boyle MP; Turriff A; Chen MA; Hinduja AS; Siebel HE; Hufnagel RB; Jeffrey BG; Brooks BP
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 35076026
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Glycemic Control on Retinal Photoreceptor Layers and Retinal Pigment Epithelium in Patients With Type 2 Diabetes Without Diabetic Retinopathy: A Follow-Up Study.
Ishibashi F; Kosaka A; Tavakoli M
Front Endocrinol (Lausanne); 2021; 12():614161. PubMed ID: 33967950
[TBL] [Abstract][Full Text] [Related]
25. The Effects of Diabetic Retinopathy and Pan-Retinal Photocoagulation on Photoreceptor Cell Function as Assessed by Dark Adaptometry.
Bavinger JC; Dunbar GE; Stem MS; Blachley TS; Kwark L; Farsiu S; Jackson GR; Gardner TW
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):208-17. PubMed ID: 26803796
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations.
Sharma S; Saxena S; Srivastav K; Shukla RK; Mishra N; Meyer CH; Kruzliak P; Khanna VK
Clin Exp Ophthalmol; 2015 Jul; 43(5):429-36. PubMed ID: 25675974
[TBL] [Abstract][Full Text] [Related]
27. Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability.
Picconi F; Parravano M; Ylli D; Pasqualetti P; Coluzzi S; Giordani I; Malandrucco I; Lauro D; Scarinci F; Giorno P; Varano M; Frontoni S
Acta Diabetol; 2017 May; 54(5):489-497. PubMed ID: 28238189
[TBL] [Abstract][Full Text] [Related]
28. Optical Coherence Tomography and Multifocal Electroretinography in Diabetic Macular Edema: A Neurovascular Relation With Vision.
Nagesh BN; Takkar B; Azad S; Azad R
Ophthalmic Surg Lasers Imaging Retina; 2016 Jul; 47(7):626-31. PubMed ID: 27434893
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of multifocal electroretinography and optical coherence tomography in eyes undergoing panretinal photocoagulation for diabetic retinopathy.
Zhu Y; Zhang T; Wang KY; Xu GZ
Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6358-64. PubMed ID: 25146984
[TBL] [Abstract][Full Text] [Related]
30. Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography.
Chhablani J; Sharma A; Goud A; Peguda HK; Rao HL; Begum VU; Barteselli G
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6333-8. PubMed ID: 26436886
[TBL] [Abstract][Full Text] [Related]
31. Resistive index of central retinal artery is a bioimaging biomarker for severity of diabetic retinopathy.
Khatri M; Saxena S; Kumar M; Chabbra AK; Bhasker SK; Akduman EI; Pham H; Akduman L
Int J Retina Vitreous; 2019; 5():38. PubMed ID: 31741747
[TBL] [Abstract][Full Text] [Related]
32. Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy.
Murakami T; Nishijima K; Sakamoto A; Ota M; Horii T; Yoshimura N
Am J Ophthalmol; 2011 Feb; 151(2):310-7. PubMed ID: 21145531
[TBL] [Abstract][Full Text] [Related]
33. Sequential restoration of external limiting membrane and ellipsoid zone after intravitreal anti-VEGF therapy in diabetic macular oedema.
De S; Saxena S; Kaur A; Mahdi AA; Misra A; Singh M; Meyer CH; Akduman L
Eye (Lond); 2021 May; 35(5):1490-1495. PubMed ID: 32690922
[TBL] [Abstract][Full Text] [Related]
34. Correlation Between Visual Function and Photoreceptor Integrity in Diabetic Macular Edema: Spectral-Domain Optical Coherence Tomography.
Shen Y; Liu K; Xu X
Curr Eye Res; 2016; 41(3):391-9. PubMed ID: 25897822
[TBL] [Abstract][Full Text] [Related]
35. Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy.
Murakami T; Uji A; Ogino K; Unoki N; Yoshitake S; Dodo Y; Horii T; Nishijima K; Yoshimura N
Jpn J Ophthalmol; 2015 Jul; 59(4):236-43. PubMed ID: 25956483
[TBL] [Abstract][Full Text] [Related]
36. Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy.
Ahuja S; Saxena S; Meyer CH; Gilhotra JS; Akduman L
Int J Retina Vitreous; 2018; 4():41. PubMed ID: 30410791
[TBL] [Abstract][Full Text] [Related]
37. Linking Retinal Microvasculature Features With Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
Bhanushali D; Anegondi N; Gadde SG; Srinivasan P; Chidambara L; Yadav NK; Sinha Roy A
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT519-25. PubMed ID: 27472275
[TBL] [Abstract][Full Text] [Related]
38. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema.
Alkuraya H; Kangave D; Abu El-Asrar AM
Int Ophthalmol; 2005 Jun; 26(3):93-9. PubMed ID: 17063373
[TBL] [Abstract][Full Text] [Related]
39. Increased serum level of homocysteine correlates with retinal nerve fiber layer thinning in diabetic retinopathy.
Srivastav K; Saxena S; Mahdi AA; Shukla RK; Meyer CH; Akduman L; Khanna VK
Mol Vis; 2016; 22():1352-1360. PubMed ID: 27994434
[TBL] [Abstract][Full Text] [Related]
40. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy.
Mohan A; Saxena S; Kaur A; Ali W; Akduman L
Mol Vis; 2021; 27():429-437. PubMed ID: 34267498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]